Product name:Sorafenib tosylate
CAS: 475207-59-1
Molecular Formula: C21H16ClF3N4O3.C7H8SO3
Molecular Weight: 637.03
Product description:A new target of anti-tumor drug, developed by Germany, bayer company, at the same time acting on tumor cells and blood vessels. It has a dual antitumor: can be mediated by blocking by the RAF/MEK/ERK signaling pathways and inhibit the proliferation of tumor cells directly, may also inhibit VEGF and platelet-derived growth factor (PDGF) receptor and the formation of tumor angiogenesis, indirectly, inhibit the growth of tumor cells.Clinical trials, sorafenib with other regular doses of antitumor drugs in the joint application, including gemcitabine and oxaliplatin into, adriamycin, and stand for. Sorafenib will not affect the gemcitabine and oxaliplatin into drug metabolism.